Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.

[1]  S. Keshavjee,et al.  The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  M. Neely,et al.  Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  S. Keshavjee,et al.  Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  M. Sato,et al.  Distinct Expression Patterns of Alveolar “Alarmins” in Subtypes of Chronic Lung Allograft Dysfunction , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  A. Kirk,et al.  Bile Acid Aspiration Associated With Lung Chemical Profile Linked to Other Biomarkers of Injury After Lung Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  E. Kovacs,et al.  The diagnostic value of gastroesophageal reflux disease (GERD) symptoms and detection of pepsin and bile acids in bronchoalveolar lavage fluid and exhaled breath condensate for identifying lung transplantation patients with GERD-induced aspiration , 2014, Surgical Endoscopy.

[8]  J. Roman,et al.  Biomarkers of pulmonary rejection. , 2013, Transplantation proceedings.

[9]  A. Bredenoord,et al.  Aspiration and Allograft Injury Secondary to Gastroesophageal Reflux Occur in the Immediate Post–Lung Transplantation Period (Prospective Clinical Trial) , 2013, Annals of surgery.

[10]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  J. Chiang.  Bile acid metabolism and signaling. , 2013, Comprehensive Physiology.

[12]  V. Kennedy,et al.  Bronchoalveolar Lavage as a Tool to Predict, Diagnose and Understand Bronchiolitis Obliterans Syndrome , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  J. Eu,et al.  Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  D. Anderson,et al.  Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. , 2011, The Annals of thoracic surgery.

[15]  P. Corris,et al.  Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life , 2011, European Respiratory Journal.

[16]  E. Trulock,et al.  Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  M. Carby,et al.  Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  G. Verleden,et al.  Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection , 2008, European Respiratory Journal.

[19]  M. Post,et al.  The Effect of Reflux and Bile Acid Aspiration on the Lung Allograft and Its Surfactant and Innate Immunity Molecules SP‐A and SP‐D , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  G. Darling,et al.  Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. , 2005, The Journal of thoracic and cardiovascular surgery.

[21]  E. Cantu,et al.  Early Fundoplication Prevents Chronic Allograft Dysfunction in Patients with Gastroesophageal Reflux Disease , 2004 .

[22]  L. Young,et al.  Lung transplantation exacerbates gastroesophageal reflux disease. , 2003, Chest.

[23]  M. Burdick,et al.  Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. , 2001, The Journal of clinical investigation.

[24]  J. Briegel,et al.  Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. , 2000, Transplantation.

[25]  G. Snell,et al.  Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation , 2000, Thorax.

[26]  J. Beynon,et al.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity , 1999, Gut.

[27]  B. Griffith,et al.  Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. , 1997, Transplantation.